Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“The existence of a circulating bone marrow-derived endothelial progenitor (BM EPC) has been a topic of controversy for the past decade, dating back to its initial description by Asahara and colleagues in 1997 [39].”
BackgroundMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Obesity has been determined as a predisposing factor for cancer development and is associated with poor prognosis of certain cancer types [50].”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Research works printed but not linked: 1
- Studeny M Marini FC Zompetta C Champlin RE Filder IJ 2001 Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood 9 697a
Cited by
Items 301–370 of 370
Hsu, C., Saleh, R. O., Mohammed, J. S., Mansuri, N., M, R. M., Kundlas, M., Anand, A., Sahoo, S., Zwamel, A. H., & Hulail, H. M. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114581 · Cited by 3
The Role of Stromal Proteolytic Systems in Cancer Progression (Review)
Kugaevskaya, E. V., Timoshenko, O. S., Gureeva, T. A., & Solovieva, N. I. (2019) · General Reanimatology · doi:10.15360/1813-9779-2019-5-106-126 · Cited by 2
“Tissues that may comprise stromal cell sources include bone marrow, connective tissue, fatty tissue, blood vessels [21, 22].”
Role of Reactive Stroma in Prostate Cancer
Martin, R. S., & Rowley, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_2 · Cited by 3
Mesenchymal Stem Cells During Tumor Formation and Dissemination
Correa, D. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0046-4 · Cited by 2
Disruption of Anti-tumor T Cell Responses by Cancer-Associated Fibroblasts
Pommier, A., & Fearon, D. T. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-42223-7_4 · Cited by 2
The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth
Ribatti, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-68448-2_7 · Cited by 3
Mechanisms of Stimulation of the Growth of Mouse Mammary Adenocarcinoma by Mesenchymal Stem Cells
Moskaleva, E. Y., Zhorova, E. S., Semochkina, Y. P., Shuvatova, V. G., Родина, А. В., & Saprykin, V. P. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05186-4 · Cited by 2
“, [10] determined the contribution of BM and AT-derived cells to the stromal а b c”
BackgroundJung, M., Ryu, Y.-J., & Kang, G. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.09.005 · Cited by 1
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.1134/s0026893323050096 · Cited by 1
An overview of the relationship between melatonin and drug resistance in cancers
Fazilat, A., Roshani, S., Moghadam, F. M., & Valilo, M. (2025) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2025-0016 · Cited by 2
Tumor Microenvironment of Epithelial Ovarian Cancer
Perkins, R. S., Choi, W.-Y., & Zhang, M. S. J. A. W. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1013212 · Cited by 3
Yuan, Y., Zhang, R., Qu, C., Huang, N., Wang, L., & Liu, M. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s581943 · Cited by 3
“3,31”
Reprogramming Cancer-associated Fibroblast: the Emerging Role of Traditional Chinese Medicine
Zhang, T., Zhang, Q., Liu, S., Zhou, L., Cheng, H., Sun, D., & Sun, Y. (2026) · Cancer Bioscience · doi:10.1016/j.cbs.2026.100003 · Cited by 1
Mo, J., Chen, J., Qu, M., Wei, J., Huang, Y., Zhou, L. Y., Yan, X., Li, J., Xu, H., Tang, B., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-16157-1 · Cited by 1
“In addition, stromal components such as endothelial cells, adipocytes, and fibroblasts represent key non-immune elements of the TME [36].”
Biology of Pericytes – Recent Advances: Role of Pericytes in Brain Metastasis
Morofuji, Y., Nakagawa, S., Fujimoto, T., Yamaguchi, S., Ujifuku, K., & Matsuo, T. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-62129-2_3 · Cited by 1
Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers
Han, L., Seward, C., Leone, G. W., & Ostrowski, M. C. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.03.003 · Cited by 1
Saha, P., Hasib, M. A., Halder, B., Sultana, S., & Rafe, M. R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106589 · Cited by 2
Mukundan, S., Sharma, K. S., Honselmann, K. C., Singleton, A., Liss, A. S., & Parekkadan, B. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818803632 · Cited by 1
“The stromal compartment undergoes significant changes at all levels from cell phenotype,(6,7) epigenetics,(8) to gene expression profile,(5,6) which are partly accounted for by activation and transdifferentiation of local cells, and partly by recruitment of new cell types into the tumors.(9) Therefore, ideal models fo…”
BackgroundAdnyana, I. G. A. (2019) · Sains Medika Jurnal Kedokteran dan Kesehatan · doi:10.30659/sainsmed.v10i2.4184 · Cited by 1
Roles of Stromal Cells in the Immune System
Roberts, E. W., Denton, A. E., & Fearon, D. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30079-7 · Cited by 1
Sun, X., Wu, C., Zhang, S., Zhao, X., & Wang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2695265/v1 · Cited by 1
Investigating the Role of Exosomal Communication in the Glioma Microenvironment
Figueroa, J. M. (2014) · Digital Commons-TMC (Texas Medical Center)
Roles of Stromal Cells in the Immune System
Roberts, E. W., Denton, A. E., & Fearon, D. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30079-7 · Cited by 1
Increased Adiposity and Endometrial Cancer Risk
Lu, K. H., Klopp, A. H., Soliman, P. T., & Schmandt, R. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_4
Self-citationValle, P. R. D. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-26032013-143422
Adipose-Derived Progenitor Cell Alterations To The Tumor Microenvironment Promote Tumorigenesis
Brooks, E. (2012) · eCommons (Cornell University)
The Role of Microenvironment Stromal Cells in Regenerative Medicine
McNiece, I. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6542-2_2
Mobilization of Adipose Stromal Cells in Obesity and Cancer by SPARC and its Proteolytic Isoforms
Tseng, C. (2015) · Digital Commons-TMC (Texas Medical Center)
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_185-1
Mesenchymal Stem/Stromal Cells and the Tumor Immune System
Walker, N. D., Nahas, G. R., Munoz, J. L., Lucas, J., Pobiarzyn, P. W., & Rameshwar, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00017-3 · Cited by 1
The Omental Fat Band as an Immunomodulatory Microenvironment for Ovarian Cancer
Cohen, C. A. (2013) · VTechWorks (Virginia Tech)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
Таширева, Л. А., Denisov, E. V., Savelieva, O. E., Gerashchenko, T. S., Zavyalova, M. V., & Михайлович, П. В. (2015) · Biopolymers and Cell · doi:10.7124/bc.000900
Expression of α-Smooth Muscle Actin Regulates the Function Of Mesenchymal Stromal Cells
Talele, N. P. (2015) · TSpace (University of Toronto)
Adipose Derived Stromal Cells in Gynecologic Cancers
Mitra, A., & Klopp, A. H. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-63483-8_7
Self-citationThe CCL5-CCR5 Axis in Breast Cancer
Sax, M. J. (2015) · Griffith Research Online · doi:10.25904/1912/3697
Lighterness, A. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122616
Multipotent Stromal Cells in a Tumor Microenvironment
Bruna, F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77345
“On the other hand, it has been reported that MSCs isolated from different sources can be found into tumor microenvironments, and depending on the level of commitment to a certain lineage by MSCs, they can be transdifferentiated faster to certain cell types depending on the source [9].”
BackgroundThe role of human bone marrow mesenchymal stromal cells in pancreatic cancer growth
Antoon, R. (2017) · TSpace (University of Toronto)
Cozzo, A. J. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/4jep-ge68
Role of Stroma in Pancreatic Cancer
Sund, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_18
MacGregor, H. L. (2020) · TSpace (University of Toronto)
Zhang, H., Zhang, X., Zhang, H., & Zhang, R. (2021) · AIP conference proceedings · doi:10.1063/5.0049383
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_185 · Cited by 1
Adipose Tissue-Derived Progenitor Cells and Cancer
Tseng, C., & Kolonin, M. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8069-3_15
Rodríguez-Pardo, V. M. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.11764
Sequeira, G. R., Sahores, A., Dalotto‐Moreno, T., Perrotta, R. M., Pataccini, G., Vanzulli, S. I., Polo, M. L., Radisky, D. C., Sartorius, C. A., Novaro, V., et al. (2023) · doi:10.1158/0008-5472.c.6512551.v1
Peña, C. M., Lee, A. H., Frare, M. F., Ghosh, D., & Dawson, M. (2023) · Current cancer research · doi:10.1007/978-3-031-22802-5_4 · Cited by 1
Alsiary, R., Katouah, H. A., Al-Amodi, H. S. A. B., & Al-Toub, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010007
Claro, F., de Angelis, C., Morare, J., Vanzela, E. C., Schiozer, W. A., Velloso, L. A., & Sarian, L. O. (2023) · Research Square · doi:10.21203/rs.3.rs-3612376/v1
Mahmoud, A. S., Khairy, D., & Elmaogod, E. A. A. (2023) · Egyptian Journal of Pathology · doi:10.4103/egjp.egjp_30_23
Claro, F., Morari, J., de Angelis, C., Vanzela, E. C., Schiozer, W. A., Velloso, L. A., & Sarian, L. O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157296 · Cited by 1
“Immunocompromised mouse models, such as athymic or SCID mice, allow engraftment of human tumors but exclude the influence of the host immune system, which is increasingly recognized as a critical regulator of tumor development, progression, and therapy response [3–5].”
Marian, M. J., & Thomson, C. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0548-5_11
Acharya, G. (2013) · Scholar Commons (University of South Carolina)
Wu, X., Ma, Z., Yang, Y., Mu, Y., & Wu, D. (2023) · Figshare · doi:10.6084/m9.figshare.24797921
Soh, S., Han, S., Ka, H. I., Mun, S. H., Kim, W., Oh, G., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590501
Soh, S., Han, S., Ka, H. I., Mun, S. H., Kim, W., Oh, G., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590498
Soh, S., Han, S., Ka, H. I., Mun, S. H., Kim, W., Oh, G., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590495
Giorello, M. B., Borzone, F. R., Sanmartin, M. C., Martinez, L. M., Sarkar, M., Sarkar, T. R., Labovsky, V., Wernicke, A., & Chasseing, N. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1766643
“Given their signi fi cant heterogeneity, not all fi broblast subpopulations across breast cancer subtypes are fully understood, particularly those potentially derived from bone marrow-MSCs, which represent a major source of stromal cells within the tumor microenvironment (9, 25 – 28).”
Fibroblastic heterogeneity and metastatic spread in breast cancers
Pelon, F. (2018) · theses.fr (ABES) · doi:10.70675/829dfe15z9dbfz4622za60cz77fac9fc8a96
Rôle du canal TRPM7 dans la prolifération des cellules stellaires pancréatiques humaines activées
Lefebvre, T. (2019) · theses.fr (ABES) · doi:10.70675/674ea5daza64cz4b92z8e11zdbf9b854c481
Stromal cells in mammary gland development and cancer
Benabid, A. (2020) · theses.fr (ABES) · doi:10.70675/8612698bz63e1z401eza0caz2b4d989c570f
Gautier‐Isola, M. (2020) · theses.fr (ABES) · doi:10.70675/b7e26a71za1e0z48e7za416z5e837ae7e8ef · Cited by 1
Cancer associated fibroblasts stimulate cancer resistance to therapy
Zajac, O. (2024) · theses.fr (ABES) · doi:10.70675/62ded90az3604z4c61zb521z8878a12ed0d9
Impact du microenvironnement des cancers du sein sur le protéome membranaire endothélial (MiMEndo).
Martin, J. (2023) · theses.fr (ABES) · doi:10.70675/f2c3b4aeze89bz4587z8dc6z19a1b07aab2b
BONE MARROW-DERIVED CELLS IN ANGIOGENESIS AND CANCER
Lauttia, S. (2014) · Työväentutkimus Vuosikirja
Vascular Targeting of Adipose Tissue
Salameh, A., & Kolonin, M. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_15
Metadata
- Authors
- Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Marini, Frank C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e30563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3282707
- OpenAlex
- W1972938311
- Cited by
- 371
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 22 · 2017: 21 · 2016: 30 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 18
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Ovarian Cancer Research Fund
- Susan G. Komen (BC083397)
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, R01NS06994, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P50CA083639, P30CA016672, CA 49639)
- National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, cancer-associated fibroblasts, mesenchymal stem cells, pericytes, myofibroblasts, endothelial cells, fibroblast activation protein, ovarian neoplasms, breast tumors, tissue transplantation
- MeSH terms
- Adipose Tissue, Animals, Bone Marrow Cells, Female, Mice, Inbred C57BL, Models, Biological, Biomarkers, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.